Comments
Loading...
Estimaciones de beneficios, BPA e ingresos
Quest Diagnostics informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Fecha de beneficios
oct 21
Estimación de BPA
$2.502
Estimación de ingresos trimestrales
$2.73B
Ingresos anuales
(a partir de jun 30)
(a partir de jun 30)
$10.52B
Analice el historial de beneficios de Quest Diagnostics utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
DGX | Quest Diagnostics | $2.30 | $2.50 | — | — | $2.49B | $2.73B | — | — | 10/21/2025 | |
DGX | Quest Diagnostics | $2.35 | $2.58 | $2.62 | 1.95% | $2.40B | $2.73B | $2.76B | 1.36% | 07/22/2025 | |
DGX | Quest Diagnostics | $2.04 | $2.15 | $2.21 | 2.79% | $2.37B | $2.63B | $2.65B | 0.84% | 04/22/2025 | |
DGX | Quest Diagnostics | $2.15 | $2.19 | $2.23 | 2.29% | $2.29B | $2.58B | $2.62B | 1.59% | 01/30/2025 | |
DGX | Quest Diagnostics | $2.22 | $2.26 | $2.30 | 1.77% | $2.29B | $2.42B | $2.49B | 2.81% | 10/22/2024 | |
DGX | Quest Diagnostics | $2.30 | $2.34 | $2.35 | 0.43% | $2.34B | $2.39B | $2.40B | 0.29% | 07/23/2024 | |
DGX | Quest Diagnostics | $2.04 | $1.85 | $2.04 | 10.27% | $2.33B | $2.29B | $2.37B | 3.32% | 04/23/2024 | |
DGX | Quest Diagnostics | $1.98 | $2.11 | $2.15 | 1.90% | $2.33B | $2.25B | $2.29B | 1.69% | 02/01/2024 | |
DGX | Quest Diagnostics | $2.36 | $2.19 | $2.22 | 1.37% | $2.49B | $2.27B | $2.29B | 1.10% | 10/24/2023 | |
DGX | Quest Diagnostics | $2.36 | $2.27 | $2.30 | 1.32% | $2.45B | $2.25B | $2.34B | 3.91% | 07/26/2023 | |
DGX | Quest Diagnostics | $3.22 | $1.97 | $2.04 | 3.55% | $2.61B | $2.20B | $2.33B | 5.95% | 04/27/2023 | |
DGX | Quest Diagnostics | $3.33 | $1.91 | $1.98 | 3.66% | $2.74B | $2.26B | $2.33B | 3.23% | 02/02/2023 | |
DGX | Quest Diagnostics | $3.96 | $2.17 | $2.36 | 8.76% | $2.77B | $2.33B | $2.49B | 6.70% | 10/20/2022 | |
DGX | Quest Diagnostics | $3.18 | $2.20 | $2.36 | 7.27% | $2.55B | $2.34B | $2.45B | 4.83% | 07/21/2022 | |
DGX | Quest Diagnostics | $3.76 | $2.97 | $3.22 | 8.42% | $2.72B | $2.63B | $2.61B | -0.72% | 04/21/2022 | |
DGX | Quest Diagnostics | $4.48 | $3.17 | $3.33 | 5.05% | $3.00B | $2.66B | $2.74B | 3.16% | 02/03/2022 | |
DGX | Quest Diagnostics | $4.31 | $2.87 | $3.96 | 37.98% | $2.79B | $2.45B | $2.77B | 13.22% | 10/21/2021 | |
DGX | Quest Diagnostics | $1.42 | $2.86 | $3.18 | 11.19% | $1.83B | $2.38B | $2.55B | 7.14% | 07/22/2021 | |
DGX | Quest Diagnostics | $0.94 | $3.71 | $3.76 | 1.35% | $1.82B | $2.64B | $2.72B | 3.03% | 04/22/2021 | |
DGX | Quest Diagnostics | $1.67 | $4.24 | $4.48 | 5.66% | $1.93B | $2.93B | $3.00B | 2.46% | 02/04/2021 | |
DGX | Quest Diagnostics | $1.76 | $3.73 | $4.31 | 15.55% | $1.96B | $2.73B | $2.79B | 2.05% | 10/22/2020 |
Quest Diagnostics (DGX) Ganancias por acción
Monto sorpresa de ganancias trimestrales
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-22 | $2.62 | $2.58 | 1.95 % |
| Q1 | 2025-04-22 | $2.21 | $2.15 | 2.79 % |
| Q4 | 2025-01-30 | $2.23 | $2.19 | 2.29 % |
| Q3 | 2024-10-22 | $2.30 | $2.26 | 1.77 % |
Quest Diagnostics (DGX) Ingresos
Monto sorpresa de ingresos trimestrales
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2025-07-22 | $2.76B | $2.73B | 1.36 % |
| Q1 | 2025-04-22 | $2.65B | $2.63B | 0.84 % |
| Q4 | 2025-01-30 | $2.62B | $2.58B | 1.59 % |
| Q3 | 2024-10-22 | $2.49B | $2.42B | 2.81 % |
PREGUNTAS FRECUENTES
¿Cuándo Quest Diagnostics (NYSE:DGX) publicará los resultados?
Está previsto que Quest Diagnostics (DGX) presente resultados el octubre 21, 2025. Los últimos resultados se publicaron el julio 22, 2025 para el Q2.
¿Cuáles han sido los últimos beneficios por acción (BPA) de Quest Diagnostics (NYSE:DGX)?
El BPA real fue de $2.62, que superó la estimación de $2.58.
¿Cuáles fueron los ingresos de Quest Diagnostics (NYSE:DGX)?
Los ingresos reales fueron $2.8B, que superó la estimación de $2.7B.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.